HealthX Ventures

HealthX Ventures is a Madison, Wisconsin-based venture capital firm that has built its reputation on deepEMR-integration expertise and strategic proximity to Epic Systems. Founded by healthcare entrepreneur Mark Bakken, who previously built Nordic into the world's largest Epic consulting firm, HealthX brings operational pedigree rarely found among seed-stage investors.

This guide covers everything you need to know about securing funding from HealthX Ventures, including their investment thesis centered on accessible, efficient, and affordable healthcare solutions, their portfolio of digital health companies, typical check sizes of $1M to $3M, and practical strategies for pitching your startup successfully.

The firm's location near Epic Systems headquarters gives HealthX a unique vantage point into the healthcare technology ecosystem. This proximity translates into tangible advantages for portfolio companies seeking EMR integrations, health system partnerships, and clinical validation within the Epic community.

Beyond capital, HealthX provides hands-on operational support and has formalized a partnership with the Nurses on Boards Coalition to place nurses on portfolio company boards—a differentiated resource that connects clinical expertise directly into governance.

HealthX evaluates digital health opportunities through the lens of scalability, cost-effectiveness, and genuine改善 of healthcare accessibility. The firm's investment approach reflects Mark Bakken's firsthand experience building and selling a healthcare IT company, giving founders access to operational guidance from someone who has navigated the same challenges.

HealthX Ventures invests in digital healthcare companies building solutions that are scalable, cost-effective, and user-friendly. The firm's thesis centers on three core outcomes: making healthcare more accessible, more efficient, and more affordable for patients and systems alike.

The firm targets seed to Series B stage companies across all areas of digital health, including telehealth, remote patient monitoring, healthcare analytics, clinical workflow automation, patient engagement platforms, and health IT infrastructure. HealthX looks for companies with genuine clinical differentiation—not incremental improvements to existing healthcare IT.

HealthX provides $1M to $3M in seed and early-stage funding. This check size positions the firm to lead or co-lead rounds while maintaining meaningful ownership for follow-on reserves. The firm's ~$20M fund size supports approximately 15-20 initial investments with reserve capacity for successful portfolio companies.

The firm's Madison location provides strategic proximity to Epic Systems headquarters, creating natural deal flow from the Epic ecosystem and enabling portfolio companies to access EMR integration expertise that would otherwise require expensive outside consultants. HealthX has capitalized on this geographic advantage by cultivating relationships with Epic employees, former employees, and the broader Epic user community.

Founder Mark Bakken brings direct experience building Nordic into a major healthcare IT services firm. This operational background enables HealthX to provide portfolio founders with guidance on navigating healthcare's complex regulatory environment, reimbursement pathways, and conservative health system sales cycles.

HealthX evaluates digital health opportunities based on clinical utility, regulatory pathway clarity, and path to reimbursement. The firm understands that healthcare technology requires different go-to-market strategies than typical SaaS, with longer sales cycles and more complex stakeholder decision-making.

HealthX Ventures's portfolio spans diverse digital health verticals, unified by the theme of improving healthcare delivery through technology. The portfolio includes companies addressing clinical decision support, chronic disease management, mental health, pharmacy services, and consumer health.

InsightRX represents HealthX's investment in AI-powered precision dosing. The platform has achieved deployments across 1,000+ hospitals, helping clinicians optimize drug dosing for individual patients and reducing adverse drug events—a compelling example of digital health delivering measurable clinical impact.

KeyCare reflects HealthX's deep Epic ecosystem connection. The company built the first Epic-native virtual care platform, enabling health systems to deploy telehealth at scale without workflow disruption. This integration-first approach exemplifies the kind of EMR-native innovation that HealthX is positioned to identify and support.

Cancer IQ raised funding from HealthX to build a precision cancer prevention platform. The company's technology empowers healthcare providers to engage patients, stratify risk, and detect cancer earlier—addressing oncology's shift toward prevention and early detection.

Empathy Health received a $7.6M Series A investment for relapse prevention tools that help patients maintain treatment protocols after initial care episodes. The company's solutions address a persistent gap in behavioral health continuity of care.

Allergy Amulet, one of HealthX's consumer health investments, developed a portable device for detecting food allergens in real-time. The company addresses food safety for the millions of Americans with severe food allergies.

Huddle Up and Bento represent HealthX's focus on whole-person health, addressing children's mental health support and food insecurity respectively—reflecting the firm's recognition that health outcomes are shaped by factors beyond traditional clinical care.

Portfolio companies benefit from HealthX's network of Midwest healthcare systems, health insurance partnerships, and the Epic user community. This regional healthcare connectivity provides validation opportunities, customer access, and potential exit pathways through strategic acquisitions.

HealthX Ventures has maintained consistent investment activity in digital health through recent market shifts. The firm's disciplined approach has focused on companies demonstrating clear clinical utility and defensible market positioning rather than those chasing valuation metrics.

Recent portfolio additions reflect HealthX's thesis around accessible and affordable care, including companies tackling chronic disease management, pharmacy services automation, and health data integration. The firm continues to back founders who understand healthcare's unique regulatory and reimbursement landscape.

HealthX has participated in follow-on rounds for strong-performing portfolio companies, demonstrating commitment to capital deployment over the full company lifecycle rather than just initial investments.

Market conditions have influenced HealthX's investment approach, with the firm maintaining selectivity while continuing to back exceptional founders. The firm's long-tenured approach and ecosystem relationships provide deal flow that surfaces high-quality opportunities.

The firm's partnership with the Nurses on Boards Coalition has created a differentiated sourcing channel, connecting HealthX with clinical innovators who might otherwise enter healthcare through different pathways.

HealthX Ventures evaluates potential investments based on several key criteria, with emphasis on founding team depth of industry knowledge, clear regulatory pathway understanding, and ability to navigate healthcare's complex reimbursement landscape.

Market opportunity is critical—HealthX seeks companies addressing large, growing markets with genuine clinical need. Products must demonstrate clear differentiation from existing solutions and evidence of early product-market fit.

Financial metrics matter, though early-stage companies may have limited historical data. HealthX looks for evidence of customer traction, strong unit economics, and realistic paths to profitability or the next funding round.

Beyond quantitative metrics, HealthX assesses founding team resilience, domain expertise, and coachability. The firm has seen thousands of pitches and looks for founders who demonstrate both conviction in their vision and flexibility in execution.

Competitive positioning is carefully evaluated. HealthX looks for companies with defensible advantages—whether proprietary technology, exclusive partnerships, or deep EMR integration that creates switching costs.

Scalability of business model remains important. HealthX prefers companies with models that can scale efficiently without proportional cost increases, particularly those with recurring revenue characteristics.

HealthX Ventures accepts cold submissions through their website at healthxventures.com/contact or via email at contact@healthxventures.com. However, warm introductions from the healthcare ecosystem remain the most effective pathway to a meeting.

The firm values connections from healthcare providers, payers, health system executives, and healthcare technology executives who can vouch for founder credibility and clinical differentiation. Building relationships within the Epic ecosystem or broader healthcare community before pitching significantly improves odds.

If pursuing a cold submission, ensure your pitch deck is polished and clearly articulates why your company fits HealthX's investment thesis. Lead with clinical differentiation, regulatory status, reimbursement pathway, and path to healthcare system adoption.

When preparing for your meeting with HealthX, be ready to discuss your business in depth. The firm will probe market size, competitive landscape, business model, traction metrics, regulatory pathway, and fundraising plans.

Following up after your initial meeting is important. HealthX typically takes several weeks to make investment decisions, so maintain professional communication without being overly pushy. Send progress updates on milestones achieved.

Building a long-term relationship with HealthX can be valuable even if your current round doesn't result in an investment. The firm may be interested in future rounds or can provide valuable introductions to other investors.

While HealthX Ventures invests in early-stage companies, they expect founders to have a solid handle on their financials. This includes understanding burn rate, runway, unit economics, and path to profitability or next funding round.

Healthcare technology companies often face longer sales cycles and more complex revenue recognition than typical SaaS. Be prepared to explain your path to revenue, reimbursement considerations, and how you model customer acquisition costs in a healthcare context.

Working with a fractional CFO can significantly improve your chances of securing funding. Professional financial guidance helps you build accurate projections, prepare investor-ready financials, and confidently answer due diligence questions.

Our team has helped numerous digital health companies raise venture capital and understands the specific financial metrics that healthcare investors scrutinize, including lifetime value, customer acquisition cost, and days sales outstanding in healthcare contexts.

Financial projections should be realistic and grounded in evidence. HealthX will scrutinize your assumptions and challenge your projections. Be prepared to explain the basis for your forecasts.

Understanding your key performance indicators is essential when pitching to HealthX. The firm values companies that track metrics aligned with healthcare adoption patterns and can articulate why specific indicators matter for your business model.

Whether you're preparing to pitch HealthX Ventures or other top digital health VCs, having professional financials can set you apart from the competition. Our team has helped companies raise capital and understands what healthcare investors look for in financial presentations.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you're looking for seed-stage investors or growth equity firms, you'll find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.